Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
methylprednisolone (medrol) (1 trial)
stromal vascular fraction (1 trial)
vasopressin (vasostrict) (1 trial)
xoma 358 (1 trial)
allogeneic adipose derived mesenchymal stem cell (1 trial)
Atrophy (Phase 2)
Congenital Hyperinsulinism (Phase 2)
Facies (Phase 2)
Hyperinsulinism (Phase 2)
Lipodystrophy (Phase 1)
Trials (4 total)
Trial APIs (5 total)